ITALY BLOOD GLUCOSE MONITORING MARKET - GROWTH, TRENDS, COVID-19 IMPACT, and Forecasts (2023 - 2028)

Italy Blood Glucose Monitoring Market is segmented by Type (Self-monitoring Blood Glucose, and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables), and Geography. The report offers market size and forecasts for all the above segments in value (USD million), and volume (unit million).

Italy Blood Glucose Monitoring Industry Overview

ItalyBGM
Study Period: 2018 - 2028
CAGR: > 9 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Italy Blood Glucose Monitoring Market Analysis

Italy Blood Glucose Monitoring Market is expected to register a CAGR greater than 9% over the forecast period, 2022-2027.

The Italian Association of Diabetes Doctors (AMD) conducted a survey among its members between February and March 2021 to assess the impact of the SARS-CoV-2 pandemic on the volume of care provided by diabetes services in Italy, as well as to analyse the measures implemented during the national lockdown. Urban health initiatives to promote healthy lifestyles through planning. Individuals' ability to understand, access, and use information in ways that promote and maintain good health is referred to as health literacy. Italy has joined the Action Network on Measuring Population and Organizational Health Literacy (M-POHL), which conducted a survey between 2019 and 2021 to establish a baseline level of health literacy that can be used to plan health policy measures to improve health literacy and track the health outcomes of such measures over time.

The International Diabetes Federation (IDF) estimated in 2021 that diabetes affected nearly 10% of the global adult population (536.6 million people), with 1.2 million children and adolescents (aged 19) suffering from type 1 diabetes. In Italy, the percentages are lower: 5.6% according to the National Institute of Statistics (ISTAT), and 4.7% according to data collected by the PASSI surveillance system among adults aged 18-69 years. ISTAT and PASSI both discovered that prevalence was higher in the southern regions than in the central and northern regions.

Italy Blood Glucose Monitoring Industry Segments

Italy Blood Glucose Monitoring Market is expected to register a CAGR greater than 9% over the forecast period. Italy Blood Glucose Monitoring Market is segmented by Type (Self-monitoring Blood Glucose, and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables), and Geography. The report offers market size and forecasts for all the above segments in value (USD million), and volume (Unit million).

Self-monitoring blood glucose devices (Value and Volume, 2016 - 2027)
Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices (Value and Volume, 2016 - 2027)
Sensors
Durables (Receivers and Transmitters)

Report scope can be customized per your requirements. Click here.

Italy Blood Glucose Monitoring Market Trends

This section covers the major market trends shaping the Italy Blood Glucose Monitoring Market according to our research experts:

Increasing Type-1 diabetes population across Italy

Diabetes mellitus affected nearly 3.8 million Italians in 2021. This was a significant increase from 2010, when 2.9 million people were affected by the disease. Over the ten years under consideration, the number of cases fluctuated along a general upward trend before peaking in 2021. The number of cases was proportional to the age of the patients. Diabetes was, in fact, much more common among the elderly than among the younger. Diabetes mellitus will affect approximately 1.1 million people aged 65 to 74 years and approximately 1.4 million people aged 75 and up in Italy in 2021. Diabetes affected both men and women equally. However, the number of females who died as a result of diabetes mellitus was greater than the number of males. Indeed, diabetes claimed the lives of over 11.7 thousand women in 2019. Diabetes poses a number of challenges for both the NHS and Italian society. The greatest challenge is the rising prevalence of diabetes, which poses real health and economic threat to the Italian health system in the future. Prevalence has steadily increased over the last decade and is expected to rise further. It has been stated that if prevalence continues to rise at this rate, the future impact on society and the economy will be unsustainable. The aging population and rising obesity are major contributors to rising prevalence. Clearly, controlling an aging population is difficult. Obesity has increased in recent years, as evidenced by the AMD Annals, owing primarily to unhealthy lifestyle choices such as poor diet and insufficient physical activity. Obesity is so closely linked to diabetes that the two conditions have been dubbed "diabesity". Meeting the demand for diabetes care is becoming increasingly difficult as diabetes prevalence rises, with diabetes centers struggling to care for an increasing number of diabetic patients. Even though diabetes centers are geographically distributed evenly.

Italypop

Continuous Glucose Monitoring Holds Highest CAGR in Italy Blood Glucose Monitoring Market.

The COVID-19 pandemic emphasizes the need for good glycemic control in patients with diabetes, in large part because most observational studies have reported that poorly controlled diabetes is associated with a higher risk for hospitalization and death from a viral illness. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. Type-1 diabetic patients need to check their blood glucose levels at regular intervals, to monitor their blood glucose levels and adjust the insulin dosing accordingly. The current CGM devices show a detailed representation of blood glucose patterns and tendencies compared to a routine check of glucose levels at set intervals. Furthermore, the current continuous glucose monitoring devices can either retrospectively display the trends in the levels of blood glucose by downloading the data or give a real-time picture of glucose levels through receiver displays.

The use of CGM by Type-1 diabetic patients is very less, as compared to Type-2 diabetic patients. But the expenditure incurred by Type-1 diabetic patients on these devices is nearly double that of Type-2 diabetics. The newest CGM models, the Abbott Freestyle Libre and the Dexcom G6 overcame many technical barriers. However, high costs and uncertainties about their efficacy and necessity have kept CGM from being widely used by people with Type-2 diabetes. Continuous glucose monitoring devices are becoming cheaper with the advent of new technologies, like cell phone integration.

ItalyBGM

Italy Blood Glucose Monitoring Market Competitor Analysis

The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by a few major players, like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped the companies to strengthen their market presence.

Italy Blood Glucose Monitoring Market Top Players

  1. Roche

  2. Abbott

  3. Dexcom

  4. Medtronics

  5. LifeScan

*Disclaimer: Major Players sorted in no particular order

ItalyBGM.png

Italy Blood Glucose Monitoring Market Recent Developments

  • In March 2022, DexCom announced the receipt of CE Mark for its G7 CGM system in Europe, intended for people who have diabetes and are two years and older, including pregnant women. With this approval, the highly popular and best-selling real-time CGM in the world is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app.
  • In Feb 2021, Roche announced the launch of the new Accu-Chek Instant system, a new "connected" blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalised Diabetes Management (iPDM). Accu-Chek Instant features Bluetooth-enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app.

Italy Blood Glucose Monitoring Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring blood glucose devices (Value and Volume, 2016 - 2027)

      1. 5.1.1 Glucometer Devices

      2. 5.1.2 Test Strips

      3. 5.1.3 Lancets

    2. 5.2 Continuous blood glucose monitoring devices (Value and Volume, 2016 - 2027)

      1. 5.2.1 Sensors

      2. 5.2.2 Durables (Receivers and Transmitters)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016 - 2027)

    2. 6.2 Type-2 Diabetes population (2016 - 2027)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche Holding AG

      3. 7.1.3 LifeScan

      4. 7.1.4 Dexcom Inc.

      5. 7.1.5 Medtronic PLC

      6. 7.1.6 Arkray Inc.

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon Laboratories Inc.

      11. 7.1.11 Trivida Functional Medicine

      12. 7.1.12 Senseonics

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Self-monitoring Blood Glucose Devices

        1. 7.2.1.1 Abbott Diabetes Care

        2. 7.2.1.2 Roche Holding AG

        3. 7.2.1.3 LifeScan

        4. 7.2.1.4 Others

      2. 7.2.2 Continuous Glucose Monitoring Devices

        1. 7.2.2.1 Dexcom Inc.

        2. 7.2.2.2 Medtronic PLC

        3. 7.2.2.3 Abbott Diabetes Care

        4. 7.2.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Italy Blood Glucose Monitoring Market Research FAQs

The Italy Blood Glucose Monitoring Market is studied from 2018 - 2028.

The Italy Blood Glucose Monitoring Market is growing at a CAGR of >9% over the next 5 years.

The Italy Blood Glucose Monitoring Market is valued at 538 Million USD in 2018.

The Italy Blood Glucose Monitoring Market is valued at 836 Million USD in 2028.

Roche, Abbott, Dexcom, Medtronics, LifeScan are the major companies operating in Italy Blood Glucose Monitoring Market.

Italy Blood Glucose Monitoring Industry Reports

In-depth industry statistics and market share insights of the Italy Blood Glucose Monitoring sector for 2020, 2021, and 2022. The Italy Blood Glucose Monitoring research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Italy Blood Glucose Monitoring report PDF.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!